Patents by Inventor Julian C. Rayner

Julian C. Rayner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IMMUNOGENIC COMPOSITIONS AND EXPRESSION SYSTEMS
    Publication number: 20180193440
    Abstract: Immunogenic compositions and vaccines against Plasmodial infection comprising an Rh polypeptide or a fragment or variant thereof are disclosed. Also disclosed are Rh5 polypeptides or fragments or variants thereof capable of binding CD147 and conferring protection against infection and/or disease caused by multiple Plasmodial strains or Plasmodial species, inhibitors of the interaction between Rh5 and CD147 and methods for producing polypeptides in a mammalian expression system.
    Type: Application
    Filed: March 5, 2018
    Publication date: July 12, 2018
    Inventors: Gavin J. WRIGHT, Julian C. RAYNER, Cecile CROSNIER, Leyla Y. BUSTAMANTE, S. Josefin BARTHOLDSON
  • IMMUNOGENIC COMPOSITIONS AND EXPRESSION SYSTEMS
    Publication number: 20170087235
    Abstract: Immunogenic compositions and vaccines against Plasmodial infection comprising an Rh polypeptide or a fragment or variant thereof are disclosed. Also disclosed are Rh5 polypeptides or fragments or variants thereof capable of binding CD147 and conferring protection against infection and/or disease caused by multiple Plasmodial strains or Plasmodial species, inhibitors of the interaction between Rh5 and CD147 and methods for producing polypeptides in a mammalian expression system.
    Type: Application
    Filed: July 7, 2016
    Publication date: March 30, 2017
    Inventors: Gavin J. WRIGHT, Julian C. RAYNER, Cecile CROSNIER, Leyla Y. BUSTAMANTE, S. Josefin BARTHOLDSON
  • IMMUNOGENIC COMPOSITIONS AND EXPRESSION SYSTEMS
    Publication number: 20140093540
    Abstract: Immunogenic compositions and vaccines against Plasmodial infection comprising an Rh polypeptide or a fragment or variant thereof are disclosed. Also disclosed are Rh5 polypeptides or fragments or variants thereof capable of binding CD147 and conferring protection against infection and/or disease caused by multiple Plasmodial strains or Plasmodial species, inhibitors of the interaction between Rh5 and CD147 and methods for producing polypeptides in a mammalian expression system.
    Type: Application
    Filed: October 7, 2011
    Publication date: April 3, 2014
    Applicant: Genome Research Limited
    Inventors: Gavin J. Wright, Julian C. Rayner, Cecile Crosner, Leyla Y. Bustamante, S. Josefin Bartholdson